menu search

Rvl pharmaceuticals plc announces $5 million registered direct offering priced at-the-market under nasdaq rules

BRIDGEWATER, N.J., Aug. 16, 2023 (GLOBE NEWSWIRE) — RVL pharmaceuticals plc (Nasdaq: RVLP) (“RVL”...

August 16, 2023, 12:00 pm

Comera life sciences announces publication of study reinforcing caffeine’s viscosity reducing capabilities

Data published in the Journal of pharmaceutical Sciences support further development of caffeine as a v...

August 16, 2023, 12:00 pm

Eton pharmaceuticals, inc. (eton) hits fresh high: is there still room to run?

Eton pharmaceuticals, Inc. (ETON) is at a 52-week high, but can investors hope for more gains in the fu...

August 16, 2023, 11:00 am

Eyenovia acquires u.s. commercial rights to app13007 (clobetasol propionate ophthalmic nanosuspension, 0.05%) from formosa pharmaceuticals

APP13007, if approved, may have an advantageous profile in dosing frequency and side effects while reducing the inflammation and pain associated with ...

August 16, 2023, 10:00 am

Why is impel pharmaceuticals (impl) stock down 35% today?

Impel pharmaceuticals (NASDAQ: IMPL ) stock is falling on Wednesday after the bio...

August 16, 2023, 8:50 am

West pharmaceutical (wst) hits 52-week high: more room to grow?

West pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products bu...

August 16, 2023, 8:43 am

Lifemd: a derivative beneficiary of the demand for anti-obesity pharmaceuticals

LifeMD is positioned for rapid growth with the introduction of a weight management program and partnerships with Nutrisystem and Medifast. The company...

August 16, 2023, 2:33 am

Apellis pharmaceuticals shareholder alert: claimsfiler reminds investors with losses in excess of $100,000 of lead plaintiff deadline in class action lawsuit against apellis pharmaceuticals, inc. – ap

NEW ORLEANS, Aug. 15, 2023 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 2,...

August 16, 2023, 2:13 am

Apellis pharmaceuticals shareholder alert: claimsfiler reminds investors with losses in excess of $100,000 of lead plaintiff deadline in class action lawsuit against apellis pharmaceuticals, inc. – ap

NEW ORLEANS, Aug. 15, 2023 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 2,...

August 16, 2023, 2:13 am

Medicinova receives a new patent covering mn-001 for the treatment of scleroderma and systemic sclerosis in europe

LA JOLLA, Calif., Aug. 15, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company trad...

August 15, 2023, 11:00 pm

Eli lilly & company (lly) remains supported in bullish sequence

Eli Lilly & Company (LLY) discovers, develops & markets human pharmaceuticals worldwide. It is based in...

August 15, 2023, 5:33 pm

Class action alert: the law offices of vincent wong remind apellis investors of a lead plaintiff deadline of october 2, 2023

NEW YORK, Aug. 15, 2023 (GLOBE NEWSWIRE) — Attention Apellis pharmaceuticals, Inc. (“Apellis”) (N...

August 15, 2023, 4:24 pm

Form 8.3 – dechra pharmaceuticals plc

U.K. DISCLOSURE, Aug. 15, 2023 (GLOBE NEWSWIRE) — FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEV...

August 15, 2023, 2:30 pm

Cardinal health (cah) beats on q4 earnings, ups '24 eps view

Cardinal Health's (CAH) fiscal fourth-quarter results benefit from the pharmaceutical segment's solid p...

August 15, 2023, 12:26 pm

60 degrees pharmaceuticals registers aclr8-lr, a phase iib study of tafenoquine for treatment of covid-19, on clinicaltrials.gov

ACLR8-LR, a double-blind, randomized, placebo-controlled Phase IIB study to determine efficacy of the ARAKODA® regimen of tafenoquine in COVID-19 pat...

August 15, 2023, 11:31 am

Okyo pharma makes good progress with flagship ok-101 drug as it wraps up its 2023 financial year

OKYO Pharma Ltd (NASDAQ:OKYO) told investors it expects to see considerable enrollments of patients in the ongoing trial of its flagship drug OK-101 t...

August 15, 2023, 9:44 am

Avicanna 2q revenue boosted by medical cannabis by shoppers drug mart acquisition

Avicanna Inc (TSX:AVCN, OTCQX:AVCNF) saw its revenue increase by 200% year-over-year in the second quarter driven by its acquisition of the Medical Ca...

August 15, 2023, 8:41 am

Pharma etf (ihe) hit a 52-week high

Investors seeking momentum may have iShares U.S. pharmaceuticals ETF IHE on radar now. The fund recentl...

August 15, 2023, 8:40 am

Cardinal health raises 2024 profit forecast on drug distribution strength

Drug distributor Cardinal Health Inc raised its 2024 profit forecast on Tuesday, as it sees strong demand for specialty and generic medicines to conti...

August 15, 2023, 8:19 am

Cardinal health beats on earnings, raises guidance on strong pharmaceutical sales

Cardinal Health reported fiscal fourth-quarter earnings of $1.55 a share on revenue of $53.5 billion....

August 15, 2023, 8:11 am


Search within

Pages Search Results: